178 related articles for article (PubMed ID: 32231079)
1. An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans.
Chaves C; Campanelli F; Chapy H; Gomez-Zepeda D; Glacial F; Smirnova M; Taghi M; Pallud J; Perrière N; Declèves X; Menet MC; Cisternino S
Pharmaceutics; 2020 Mar; 12(4):. PubMed ID: 32231079
[TBL] [Abstract][Full Text] [Related]
2. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.
Sala-Rabanal M; Li DC; Dake GR; Kurata HT; Inyushin M; Skatchkov SN; Nichols CG
Mol Pharm; 2013 Apr; 10(4):1450-8. PubMed ID: 23458604
[TBL] [Abstract][Full Text] [Related]
3. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
5. Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
Wang M; Sun Y; Hu B; He Z; Chen S; Qi D; An H; Wei Y
Curr Drug Deliv; 2022; 19(4):508-517. PubMed ID: 34238184
[TBL] [Abstract][Full Text] [Related]
6. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporter mRNA and function in the rat superior cervical ganglion.
Kristufek D; Rudorfer W; Pifl C; Huck S
J Physiol; 2002 Aug; 543(Pt 1):117-34. PubMed ID: 12181285
[TBL] [Abstract][Full Text] [Related]
8. Organic cation transporters: physiology, toxicology and special focus on ethidium as a novel substrate.
Lee WK; Wolff NA; Thévenod F
Curr Drug Metab; 2009 Jul; 10(6):617-31. PubMed ID: 19702534
[TBL] [Abstract][Full Text] [Related]
9. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
10. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.
Gasser PJ; Lowry CA; Orchinik M
J Neurosci; 2006 Aug; 26(34):8758-66. PubMed ID: 16928864
[TBL] [Abstract][Full Text] [Related]
11. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
12. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA
Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690
[TBL] [Abstract][Full Text] [Related]
13. Organic Cation Transporters (OCTs) in EpiAirway™, A Cellular Model of Normal Human Bronchial Epithelium.
Barilli A; Visigalli R; Ferrari F; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V; Rotoli BM
Biomedicines; 2020 May; 8(5):. PubMed ID: 32438722
[TBL] [Abstract][Full Text] [Related]
14. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Amphoux A; Vialou V; Drescher E; Brüss M; Mannoury La Cour C; Rochat C; Millan MJ; Giros B; Bönisch H; Gautron S
Neuropharmacology; 2006 Jun; 50(8):941-52. PubMed ID: 16581093
[TBL] [Abstract][Full Text] [Related]
15. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.
Amphoux A; Millan MJ; Cordi A; Bönisch H; Vialou V; Mannoury la Cour C; Dupuis DS; Giros B; Gautron S
Eur J Pharmacol; 2010 May; 634(1-3):1-9. PubMed ID: 20170649
[TBL] [Abstract][Full Text] [Related]
18. Organic Cation Transporters in Health and Disease.
Koepsell H
Pharmacol Rev; 2020 Jan; 72(1):253-319. PubMed ID: 31852803
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
20. Selective substrates for non-neuronal monoamine transporters.
Gründemann D; Liebich G; Kiefer N; Köster S; Schömig E
Mol Pharmacol; 1999 Jul; 56(1):1-10. PubMed ID: 10385678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
